Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytogenetic study of 33 ependymomas.

A M Vagner-Capodano1, H Zattara-Cannoni, D Gambarelli

  • 1Cytogenetic Oncology Laboratory, CHU Timone, Marseille, France.

Cancer Genetics and Cytogenetics
|December 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI Analysis.

AJNR. American journal of neuroradiology·2024
Same author

Molecular and clinical diversity in primary central nervous system lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome.

Neuro-Chirurgie·2021
Same author

Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.

Journal of neuro-oncology·2020
Same author

A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas.

Neuropathology and applied neurobiology·2020

This study investigated cytogenetic changes in 33 ependymomas, including recurrent tumors. Findings aim to identify predictive factors for ependymoma outcomes, as specific chromosomal changes remain largely undescribed.

Area of Science:

  • Neuro-oncology
  • Cytogenetics
  • Tumor Biology

Background:

  • Ependymomas are glial tumors comprising 5-10% of intracranial neoplasms.
  • These tumors have the potential to recur, yet predictive factors for patient outcomes are not well-established.
  • Existing karyotypic data on ependymomas is limited, with no specific chromosomal alterations consistently identified.

Purpose of the Study:

  • To conduct a cytogenetic analysis of ependymomas.
  • To determine the frequency and types of chromosomal changes in these tumors.
  • To explore potential cytogenetic markers associated with ependymoma recurrence and prognosis.

Main Methods:

  • Karyotypic analysis was performed on a cohort of 33 ependymoma samples.
  • The study included eight cases of recurrent ependymomas.

Related Experiment Videos

  • Standard cytogenetic techniques were employed to identify chromosomal abnormalities.

    • Main Results:

    • The study identified specific cytogenetic alterations in a subset of the analyzed ependymomas.
    • The incidence and types of chromosomal changes varied among the primary and recurrent tumors.
    • Detailed cytogenetic profiles were established for the investigated ependymoma cases.

    Conclusions:

    • Cytogenetic analysis can reveal specific chromosomal changes in ependymomas.
    • These findings may contribute to understanding the molecular basis of ependymoma development and recurrence.
    • Further research is warranted to correlate cytogenetic findings with clinical outcomes in ependymoma patients.